logo

JANX

Janux Therapeutics·NASDAQ
--
--(--)
--
--(--)

JANX fundamentals

Janux Therapeutics (JANX) released its earnings on Aug 7, 2025: revenue was 0 (YoY -100.00%), missed estimates; EPS was -0.55 (YoY -400.00%), missed estimates.
Revenue / YoY
0
-100.00%
EPS / YoY
-0.55
-400.00%
Report date
Aug 7, 2025

Earnings

EPS
Revenue

Revenue & Expenses

Key Indicators

Janux Therapeutics (JANX) key financial stats and ratios, covering profitability, financial health, and leverage.

Income Statement

Janux Therapeutics (JANX)'s revenue and profit trends over recent years, visualized with a waterfall chart to showcase the revenue-to-profit funnel.
Trend
Breakdown

Balance Sheet

Janux Therapeutics (JANX)'s asset and liability trends over recent years, visualized with a waterfall chart to illustrate changes in its asset-liability structure.
Trend
Breakdown

Cash Flow

Janux Therapeutics (JANX)'s cash flow trends over recent years, visualized with a waterfall chart to illustrate changes in its operating, investing, and financing cash flows.
Trend
Breakdown

Revenue Breakdown

Where does Janux Therapeutics (JANX) generate its revenue? Explore its key revenue streams and top earning regions.
By Business
Data source:
By Region
Data source:

Dividend

Track Janux Therapeutics (JANX) Dividend Yield, Payout Ratio & Sustainability Through Its Dividend History
Payout Ratio
Dividend Yield